25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34496864 | Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus. | 2021 Sep 8 | 1 |
2 | 34648889 | Characteristics of the clinical treatment of Brazilian and French older adults with diabetes. | 2021 Nov | 1 |
3 | 32430781 | Factors associated with poor-to-moderate quality of life among pregnant women with gestational diabetes mellitus: a cross-sectional study in Malaysia. | 2020 Oct | 1 |
4 | 29200880 | Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database. | 2017 | 2 |
5 | 25048394 | Predictive factors for the efficacy of switch to oral hypoglycemic agents in Japanese type 2 diabetic patients with intensive insulin therapy temporarily introduced. | 2014 | 2 |
6 | 22830956 | The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. | 2012 Dec | 1 |
7 | 22973308 | Free Triiodothyronine and Cholesterol Levels in Euthyroid Elderly T2DM Patients. | 2012 | 1 |
8 | 21458350 | Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus. | 2011 Nov | 2 |
9 | 22028157 | Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes. | 2011 Nov | 1 |
10 | 19890623 | Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. | 2010 Mar | 1 |
11 | 20356473 | [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.]. | 2010 Jan | 1 |
12 | 17475531 | Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes. | 2007 Sep | 1 |
13 | 17565917 | Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States. | 2007 Mar-Apr | 7 |
14 | 17727695 | Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. | 2007 Aug 29 | 1 |
15 | 15586391 | Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects. | 2005 May-Jun | 1 |
16 | 12174320 | Before oral agents fail: the case for starting insulin early. | 2002 Sep | 1 |
17 | 12408284 | Current perspective in insulin therapy in the management of diabetes mellitus. | 2002 Mar | 1 |
18 | 11523910 | The influence of long-term different diabetic therapies on plasma leptin in type 2 diabetic subjects. | 2001 Jun | 1 |
19 | 10332674 | Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997. | 1999 May | 1 |
20 | 9069587 | Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. | 1997 Mar | 4 |
21 | 9288551 | Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins. | 1997 | 1 |
22 | 8480059 | [Diabetes mellitus in the elderly: a study on its clinical presentation, C-peptide reserve, and immunogenetic markers of insulin dependence]. | 1993 Mar | 1 |
23 | 1314198 | Secondary failure of oral hypoglycaemic agents in lean patients with type 2 diabetes mellitus: insulin sensitivity, insulin response to different stimuli, and the role of cyclic-AMP. | 1992 Jan-Feb | 2 |
24 | 1634193 | The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy. | 1992 Jun | 1 |
25 | 2123183 | Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. | 1990 Aug | 1 |